The contribution of rapamycin-insensitive processes to neurological symptoms in TSC. New award

The Children's Hospital Corporation, doing business as Boston Children's Hospital, was awarded a $796,500 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program.

The grant will fund research from July 2021 through June 2024 to investigate the contribution of rapamycin-insensitive processes to neurological symptoms in tuberous sclerosis complex. The Military Medical Research and Development program aims to advance biomedical research and develop medical solutions for service members and the public through initiatives like supporting research into conditions like tuberous sclerosis complex. The three-year period of performance and funding amount indicate Boston Children's Hospital will conduct a comprehensive research program over this timeframe to better understand neurological issues in this condition and potentially identify new treatment approaches.